Read More 1 minute read Biotechnology M&A News News Merck to Acquire Eyebiotech Limited for $3 Billion Key Highlights Merck acquires Eyebiotech for up to $3 billion Eyebiotech’s Restoret™ to advance into pivotal trials in… byChris-Anne RoqueMay 30, 2024